Abstract
To gain global insights into the role of the well-known repressive splicing regulator PTB, we analyzed the consequences of PTB knockdown in HeLa cells using high-density oligonucleotide splice-sensitive microarrays. The major class of identified PTB-regulated splicing event was PTB-repressed cassette exons, but there was also a substantial number of PTB-activated splicing events. PTB-repressed and PTB-activated exons showed a distinct arrangement of motifs with pyrimidine-rich motif enrichment within and upstream of repressed exons but downstream of activated exons. The N-terminal half of PTB was sufficient to activate splicing when recruited downstream of a PTB-activated exon. Moreover, insertion of an upstream pyrimidine tract was sufficient to convert a PTB-activated exon to a PTB-repressed exon. Our results show that PTB, an archetypal splicing repressor, has variable splicing activity that predictably depends upon its binding location with respect to target exons.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen, M. & Manley, J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741–754 (2009).
Matlin, A.J., Clark, F. & Smith, C.W. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6, 386–398 (2005).
Blencowe, B.J. Alternative splicing: new insights from global analyses. Cell 126, 37–47 (2006).
Wang, Z. & Burge, C.B. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14, 802–813 (2008).
Barash, Y. et al. Deciphering the splicing code. Nature 465, 53–59 (2010).
Castle, J.C. et al. Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat. Genet. 40, 1416–1425 (2008).
Kalsotra, A. et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA 105, 20333–20338 (2008).
Wang, E.T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008).
Wagner, E.J. & Garcia-Blanco, M.A. Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21, 3281–3288 (2001).
Spellman, R. & Smith, C.W. Novel modes of splicing repression by PTB. Trends Biochem. Sci. 31, 73–76 (2006).
Sawicka, K., Bushell, M., Spriggs, K.A. & Willis, A.E. Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans. 36, 641–647 (2008).
Oberstrass, F.C. et al. Structure of PTB bound to RNA: specific binding and implications for splicing regulation. Science 309, 2054–2057 (2005).
Perez, I., McAfee, J.G. & Patton, J.G. Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry 36, 11881–11890 (1997).
Reid, D.C. et al. Next-generation SELEX identifies sequence and structural determinants of splicing factor binding in human pre-mRNA sequence. RNA 15, 2385–2397 (2009).
Amir-Ahmady, B., Boutz, P.L., Markovtsov, V., Phillips, M.L. & Black, D.L. Exon repression by polypyrimidine tract binding protein. RNA 11, 699–716 (2005).
Ashiya, M. & Grabowski, P.J. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 3, 996–1015 (1997).
Gooding, C., Roberts, G.C. & Smith, C.W. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated α-tropomyosin exon. RNA 4, 85–100 (1998).
Perez, I., Lin, C.H., McAfee, J.G. & Patton, J.G. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo . RNA 3, 764–778 (1997).
Lin, C.H. & Patton, J.G. Regulation of alternative 3′ splice site selection by constitutive splicing factors. RNA 1, 234–245 (1995).
Singh, R., Valcarcel, J. & Green, M.R. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268, 1173–1176 (1995).
Izquierdo, J.M. et al. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 19, 475–484 (2005).
Sharma, S., Falick, A.M. & Black, D.L. Polypyrimidine tract binding protein blocks the 5′ splice site-dependent assembly of U2AF and the prespliceosomal E complex. Mol. Cell 19, 485–496 (2005).
Sharma, S., Kohlstaedt, L.A., Damianov, A., Rio, D.C. & Black, D.L. Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome. Nat. Struct. Mol. Biol. 15, 183–191 (2008).
Chou, M.Y., Underwood, J.G., Nikolic, J., Luu, M.H. & Black, D.L. Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell 5, 949–957 (2000).
Matlin, A.J., Southby, J., Gooding, C. & Smith, C.W. Repression of α-actinin SM exon splicing by assisted binding of PTB to the polypyrimidine tract. RNA 13, 1214–1223 (2007).
Robinson, F. & Smith, C.W. A splicing repressor domain in polypyrimidine tract-binding protein. J. Biol. Chem. 281, 800–806 (2006).
Boutz, P.L. et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 21, 1636–1652 (2007).
Xing, Y. et al. MADS: a new and improved method for analysis of differential alternative splicing by exon-tiling microarrays. RNA 14, 1470–1479 (2008).
Lou, H., Helfman, D.M., Gagel, R.F. & Berget, S.M. Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3′-terminal exon. Mol. Cell. Biol. 19, 78–85 (1999).
Paradis, C. et al. hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c. RNA 13, 1287–1300 (2007).
Xue, Y. et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell 36, 996–1006 (2009).
Ule, J. et al. An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580–586 (2006).
Venables, J.P. et al. Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol. 16, 670–676 (2009).
Yeo, G.W. et al. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16, 130–137 (2009).
Zhang, C. et al. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 22, 2550–2563 (2008).
Du, H. et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17, 187–193 (2010).
Spellman, R., Llorian, M. & Smith, C.W. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol. Cell 27, 420–434 (2007).
Yamamoto, M.L. et al. Alternative pre-mRNA splicing switches modulate gene expression in late erythropoiesis. Blood 113, 3363–3370 (2009).
Clark, T.A. et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol. 8, R64 (2007).
Smith, C.W. Alternative splicing–when two's a crowd. Cell 123, 1–3 (2005).
Mendell, J.T., ap Rhys, C.M. & Dietz, H.C. Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts. Science 298, 419–422 (2002).
Mi, H., Guo, N., Kejariwal, A. & Thomas, P.D. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res. 35, D247–D252 (2007).
Makeyev, E.V., Zhang, J., Carrasco, M.A. & Maniatis, T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27, 435–448 (2007).
Ule, J. et al. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37, 844–852 (2005).
Christofk, H.R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230–233 (2008).
Thorsen, K. et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol. Cell. Proteomics 7, 1214–1224 (2008).
He, X. et al. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro . Oncogene 26, 4961–4968 (2007).
Wang, C. et al. Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner. J. Biol. Chem. 283, 20277–20287 (2008).
David, C.J., Chen, M., Assanah, M., Cannoll, P. & Manley, J.L. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463, 364–368 (2010).
Gooding, C. et al. A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones. Genome Biol. 7, R1 (2006).
Goers, E.S., Purcell, J., Voelker, R.B., Gates, D.P. & Berglund, J.A. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res. 38, 2467–2484 (2010).
Jin, Y. et al. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J. 22, 905–912 (2003).
Faustino, N.A. & Cooper, T.A. Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol. 25, 879–887 (2005).
Goren, A. et al. Comparative analysis identifies exonic splicing regulatory sequences–the complex definition of enhancers and silencers. Mol. Cell 22, 769–781 (2006).
Wagner, E.J. & Garcia-Blanco, M.A. RNAi-mediated PTB depletion leads to enhanced exon definition. Mol. Cell 10, 943–949 (2002).
Del Gatto-Konczak, F., Olive, M., Gesnel, M.C. & Breathnach, R. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19, 251–260 (1999).
Venables, J.P. Downstream intronic splicing enhancers. FEBS Lett. 581, 4127–4131 (2007).
Forch, P., Puig, O., Martinez, C., Seraphin, B. & Valcarcel, J. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J. 21, 6882–6892 (2002).
Rideau, A.P. et al. A peptide motif in Raver1 mediates splicing repression by interaction with the PTB RRM2 domain. Nat. Struct. Mol. Biol. 13, 839–848 (2006).
Wollerton, M.C., Gooding, C., Wagner, E.J., Garcia-Blanco, M.A. & Smith, C.W. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell 13, 91–100 (2004).
Coles, J.L., Hallegger, M. & Smith, C.W. A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F. RNA 15, 33–43 (2009).
Hunt, S.L. & Jackson, R.J. Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA 5, 344–359 (1999).
Ellis, P.D., Smith, C.W. & Kemp, P. Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by α-tropomyosin regulatory elements in transgenic mice. J. Biol. Chem. 279, 36660–36669 (2004).
Schwartz, S. et al. Alu exonization events reveal features required for precise recognition of exons by the splicing machinery. PLOS Comput. Biol. 5, e1000300 (2009).
Shapiro, M.B. & Senapathy, P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15, 7155–7174 (1987).
Carmel, I., Tal, S., Vig, I. & Ast, G. Comparative analysis detects dependencies among the 5′ splice-site positions. RNA 10, 828–840 (2004).
Yeo, G. & Burge, C.B. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377–394 (2004).
Schwartz, S.H. et al. Large-scale comparative analysis of splicing signals and their corresponding splicing factors in eukaryotes. Genome Res. 18, 88–103 (2008).
Bembom, O. seqLogo: an R package for plotting DNA sequence logos. (2007).
R Development Core Team. R: a language and environment for statistical computing. (2009).
Acknowledgements
We thank M. Hallegger, N. McGlincy and J. Ule for comments on the manuscript. This work was supported by a Wellcome Trust programme grant to C.W.J.S. (077877) and European Commission grant EURASNET-LSHG-CT-2005-518238 (C.W.J.S. and G.A.). G.A. is supported by grants from the Israel Science Foundation (ISF 61/09), Joint Germany-Israeli Research Program (ca-139), Deutsche-Israel Project (DIP MI-1317), the Israel Cancer Association and the Israel Cancer Research Foundation (ICRF). P.G. was supported by the Association Française contre les Myopathies and European Commission grant EURASNET-LSHG-CT-2005-518238. S.S. and D.H. are fellows of the Edmond J. Safra bioinformatics program at Tel Aviv University. This work was performed in partial fulfillment of the requirements for a PhD degree of S.S. and D.H., Sackler Faculty of Medicine, Tel Aviv University, Israel.
Author information
Authors and Affiliations
Contributions
M.L. and R.S. prepared materials for array analyses; T.A.C. and A.C.S. carried out the array analyses; M.L., L.-Y.T. and A.G. validated array predictions; S.S., D.H., P.G. and G.A. carried out bioinformatic analyses; M.L. carried out all other wet experimental work; M.L., S.S. and C.W.J.S. wrote the manuscript with input from other authors; C.W.J.S. conceived the project and coordinated the collaborations with important input from G.A., M.L., S.S. and T.A.C.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–4, Supplementary Table 1, Supplementary Data 1 and 2 (PDF 917 kb)
Rights and permissions
About this article
Cite this article
Llorian, M., Schwartz, S., Clark, T. et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol 17, 1114–1123 (2010). https://doi.org/10.1038/nsmb.1881
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.1881
This article is cited by
-
The role of alternative splicing in lung cancer
Cancer Chemotherapy and Pharmacology (2023)
-
The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression
Cell Death & Disease (2022)
-
ASCOT identifies key regulators of neuronal subtype-specific splicing
Nature Communications (2020)
-
Advances in transcriptome analysis of human brain aging
Experimental & Molecular Medicine (2020)
-
Diversification of the muscle proteome through alternative splicing
Skeletal Muscle (2018)